Navigation Links
CareFusion Announces 510(k) Clearance and U.S. Launch of New Advanced Electrodiagnostic System
Date:3/20/2012

SAN DIEGO, March 20, 2012 /PRNewswire/ -- CareFusion announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new electrodiagnostic system, known as the Viking on Nicolet® EDX. The EDX system is a multi-modality device for monitoring and testing electrophysiological information from the human nervous and muscular system.

(Logo: http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO)

The new EDX system offers an intuitive, ergonomic platform and clinical automation that enables efficient, high-quality nerve conduction studies (NCS), electromyography (EMG) and evoked potential (EP) testing and intra-operative monitoring (IOM). The strong signal quality, environmental noise suppression capability and artifact rejection feature help reduce examination time, which can enhance patient comfort. 

Designed with input from neurologists and electrodiagnostic technicians, the EDX system also helps improve workflow in busy clinical settings by effectively organizing data into a variety of reporting formats. With the versatile system, clinicians can complete their studies and generate reports with ease, helping to streamline workflow, improve clinician efficiency and lower costs.

"We are excited to bring the Viking on Nicolet EDX system to the U.S. market," said Mary de Sousa, vice president and general manager of the Nicolet business of CareFusion. "The EDX system helps strengthen our market-leading EMG portfolio and ensures clinicians and patients can benefit from the latest advancements in neurological care."

The EDX system will now be available in the United States and many other countries worldwide. The product will also be featured at the CareFusion booth at the American Academy of Neurology conference in New Orleans from April 23-26. Visit CareFusion at booth #801.

About CareFusion
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife™ and LTV® series ventilation and respiratory products, ChloraPrep® skin prep products, MedMined® services for data mining surveillance, Nicolet™ neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 14,000 people across its global operations. More information may be found at www.carefusion.com.


'/>"/>
SOURCE CareFusion
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CareFusion Reports First Quarter Fiscal 2012 Results
2. ERT Closes the Acquisition of the Research Services Division of CareFusion Corporation
3. GeoVax Announces Private Placement of $2.2 Million
4. Jennerex Announces First Patient Treated in Phase 1/2 Clinical Trial of JX-594 in Combination with Irinotecan in Patients with Metastatic Colorectal Cancer
5. Organovo Announces Close of $15.2 Million Private Placement to Advance 3D Bioprinting for Medical Applications
6. Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA® for the Acute Treatment of Migraine
7. Floridas Leading Fertility Center Announces Successful Baby Delivery via Egg Freezing
8. Synthetic Biologics Announces Completion of Enrollment in 164 Patient Clinical Trial of Oral Trimesta™ for Multiple Sclerosis
9. Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting
10. Proteonomix Announces a Private Placement of $3.8 Million
11. Updated: Life Technologies Announces Fourth Quarter and Fiscal Year 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... ... August 11, 2017 , ... Algenist continues to disrupt ... unlocking collagen like never before. , Collagen is the key structural element skin ... with Liquid Collagen™, which include: , First to market ...
(Date:8/10/2017)... ... August 09, 2017 , ... Teachers from three Philadelphia ... August 14th through the 16th, the University City Science Center will kick off ... 2016, provides Philadelphia-based middle school educators an opportunity for professional development related to ...
(Date:8/10/2017)... , ... August 09, 2017 , ... Okyanos Center for ... place at the Pelican Bay Hotel in Freeport, Grand Bahama on September 27, 2017. ... required. , With oversight from the Ministry of Health’s National Stem Cell Ethics ...
(Date:8/10/2017)... UK (PRWEB) , ... August 10, 2017 , ... ... announced an agreement establishing Kinokuniya Company Ltd. as its exclusive sales representative for ... exclusive sales representative for the SPIE Digital Library in Japan. , “We look ...
Breaking Biology Technology:
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
Breaking Biology News(10 mins):